# Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer

> **NCT00660842** · PHASE3 · UNKNOWN · sponsor: **National Cancer Institute, Naples** · enrollment: 800 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **PROCEDURE:** carboplatin
- **DRUG:** paclitaxel
- **DRUG:** carboplatin
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00660842
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2024-11
- **Final completion:** 2024-11
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00660842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00660842, "Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00660842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*